ew medical specialties have faced such groundbreaking changes in such a short time, as Neurology did, leaving its hazy and somewhat mystical but nihilistic air, turning into a modern, scientific and often treatable medical area. Moreover, general diagnostic and treatment strategies have often given way their way to tailored approaches. Indeed, thanks to the major changes in the diagnosis and treatment of cerebrovascular diseases, particularly in ischemic stroke, the most common neurological disease, nowadays we can halve stroke-related disability. The advent of monoclonal antibodies dramatically changed the quality of life of people suffering from episode and chronic migraines and is about to revolutionize the treatment of dementias. Multiple sclerosis and neuro-immunological CNS and PNS disorders can now benefit from modern diagnostic criteria and innovative care, significantly modifying the course of the diseases. Moreover, new and more tolerable drugs expanded the treatment options for epilepsy and new frontiers are being explored in the management of advanced Parkinson’s disease.
However…
Is it all so clear? Is there enough and robust evidence supporting our everyday clinical decision-making? The aim of this conference is to shed light on many persisting grey areas in Neurology. Experts in specific fields will take turns, giving their point of view, and, whenever possible, trying to solve your doubts in a friendly and captivating discussion.